Search results
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
Clinical Trials Arena via Yahoo Finance· 5 days agoInnovent Biologics has said that its type 2 diabetes (T2D) candidate mazdutide was superior to Eli...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 6 days agoIn the first quarter, sales of weight-loss drug Zepbound skyrocketed and topped Wall Street's...
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes
FierceBiotech· 6 days agoInnovent has scored another phase 3 win for mazdutide as the drug showed its superiority to Eli...
GLP-1s: 8 things hospital leaders should know
Becker’s Hospital Review· 7 days agoA blockbuster drug class that includes Ozempic, Wegovy and Trulicity is pioneering avenues in the healthcare industry and redefining obesity care as the weight loss therapy ...
Analyst Report: Eli Lilly and Company
Morningstar Research via Yahoo Finance· 1 day agoEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity ...
...Finds 1 in 8 Adults Say They’ve Taken a GLP-1 Drug (Ozempic, Trulicity, Wegovy), Including 4 in...
Sierra Sun Times· 2 days agoAbout one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce ...
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
Morningstar· 1 day agoWith strong pricing power and sales growth of key drugs, here’s what we think of Lilly’s stock. Eli...
Is it ever OK to ask if someone's on Ozempic? Here's what experts say about questions regarding...
Yahoo Life Style via AOL· 5 days agoWhat's the etiquette for asking about weight loss in the age of Ozempic? Here's what experts — and...
1 in 8 adults has taken Ozempic or other GLP-1 drug: Survey
The Hill via Yahoo News· 5 days agoA poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 2 days agoAn analysis of patent applications for 10 top-selling prescription drugs found that nearly...
